Farther Finance Advisors’s Liminatus Pharma LIMN Stock Holding History

Farther Finance Advisors’s Portfolio LIMN Stock Details LIMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14	Closed	-$2	–	6155
2026 Q1	$2	Sell	14 -17	-55%	-$9	﹤0.01%	5741
2025 Q4	$19	Hold	31	–	–	﹤0.01%	5398
2025 Q3	$52	Buy	+31	New	+$134	﹤0.01%	4869

Farther Finance Advisors's LIMN Position: Q2 2026 in Review

Farther Finance Advisors sold out of Liminatus Pharma (LIMN) in Q2 2026, closing a stake of 14 shares — an estimated $2 sold.

Farther Finance Advisors first reported a position in LIMN in Q3 2025 and held it in 3 quarters. The position peaked at $52 in Q3 2025. 0 funds tracked by Wall St. Rank hold LIMN as of Q2 2026.

Farther Finance Advisors reported no remaining Liminatus Pharma position as of Q2 2026 after selling out during the quarter.
Farther Finance Advisors sold 14 Liminatus Pharma shares in Q2 2026, an estimated $2.
Farther Finance Advisors first reported a position in Liminatus Pharma in Q3 2025 and held it in 3 quarters.
Farther Finance Advisors's Liminatus Pharma position peaked at $52 in Q3 2025.
0 funds tracked by Wall St. Rank held Liminatus Pharma as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.